In a notable performance, Becton Dickinson and Co. (NYSE:BDX) stock achieved a 52-week high, reaching a price level of ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $243.45 which represents a slight increase of $2.98 or 1.24% from the prior close of $240.47. The stock opened at $239 and ...

Brighton Jones LLC raised its holdings in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 98.2% in the ...

Atomi Financial Group Inc. lifted its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 25.3% in the ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy ...

Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...

Becton Dickinson plans to invest more than $30M in 2025 to expand its manufacturing capacity for IV lines at its Utah plant.

近日，贝克顿·迪金森公司 (Becton Dickinson & Co) (NYSE: BDX )执行副总裁兼首席ISC官Shan David出售了500股公司普通股。每股售价为240.00美元，总计12万美元。此次出售后，David仍持有公司5,741股股份。

Company will spotlight sustainable solutions to enhance patient safety, workforce well-being, and care delivery efficiency ...

贝克顿·迪金森公司 (Becton Dickinson & Co.) (NYSE: BDX )执行副总裁兼医疗部门总裁Michael David Garrison最近出售了597股公司普通股。这些股票以平均价格236.51美元售出，交易总额为141,196美元。此次出售后，Garrison直接持有5,544股。

Becton Dickinson & Co. closed 3.20% below its 52-week high of $248.42, which the company achieved on March 28th.